One of the significant risks associated with the use of donor T cells is graft-versus-host disease (GVHD), where the donor immune cells attack the recipient's healthy tissues. This can lead to severe complications and requires careful management. Other potential risks include infections and the possibility of the donor T cells attacking normal cells, leading to off-target effects.
